Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001340978 | SCV001534814 | uncertain significance | Charcot-Marie-Tooth disease type 2 | 2020-07-26 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MED25 cause disease. This variant has not been reported in the literature in individuals with MED25-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu309Serfs*68) in the MED25 gene. It is expected to result in an absent or disrupted protein product. |
Ambry Genetics | RCV002546921 | SCV003582300 | pathogenic | Inborn genetic diseases | 2022-01-06 | criteria provided, single submitter | clinical testing | The c.924delT (p.L309Sfs*68) alteration, located in exon 9 (coding exon 9) of the MED25 gene, consists of a deletion of one nucleotide at position 924, causing a translational frameshift with a predicted alternate stop codon after 68 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. |